Patent · US Active

Salicylate and gentisate salts of a piperazine compound

US7615551B2 · kind B2 · utility

0Cited by

5References

25Claims

0Family size

Assignee

Solvay Pharmaceuticals, B.V. · NL

Inventors

Subodh Deshmukh · White Plains, US
Kadum Ali · Congers, US
Christopher Diorio · Campbell Hall, US
Wendy Ann Dulin · Ramapo, US
Eric C. Ehrnsperger · New City, US
Mahdi B. Fawzi · Morristown, US
Syed M. Shah · Delray Beach, US

Key dates

Filing date	Sep 12, 2006
Grant date	Nov 10, 2009
Priority date	—
Expiry date	Oct 15, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides salt forms, and compositions thereof, useful as modulators of one or more GPCRs and which exhibit desirable characteristics for the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.